Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001610717-26-000002

Chief Financial Officer sold 6,552 shares at $23.38 ($153,186)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goeltz II Robert C. Chief Financial Officer 2025-12-31 Sale 10b5-1 −6,552 $23.38 $153,186 67,924 D: show line 1 in the form
Open-market sales · 6,552 sh · avg $23.38 · $153,186
Loading xslF345X05/form4.xml…